SLBTNasdaq

SL Science Holding Ltd

Healthcare·Healthcare·Taipei, Taiwan

SL Science Holding Ltd (SLBT): 28 pipeline candidates. Updated within the last hour.

Key Financials

Market Cap

$3.6B

Cash

—

Quarterly Burn

—

Runway

—

Revenue

—

Pipeline (28 candidates)

DrugPhase
3.0 dynamic tibase—
b.t.i. biotechnology institute—
bti dental implant 5.5-6.5—
bti dental implant system unicca—
bti dental implant system unicca – aesthetic post abutments—
bti dental implant tiny 2.5-3.0—
bti endosseous dental implant angled abutments—
bti extra-short dental implant system unicca—
bti interna 3.0 dental implant system unicca—
bti interna dental implant system—

Showing 10 of 28 candidates. Sign up for full pipeline.

Frequently asked questions

How many drug candidates are in SL Science Holding Ltd's pipeline?

SL Science Holding Ltd (SLBT) has 28 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is SL Science Holding Ltd's market capitalization?

SL Science Holding Ltd's market capitalization is approximately $3.6B.

Get the full picture on SL Science Holding Ltd

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar